These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 13536996)

  • 1. Structure-activity relationships among purines related to 6-mercaptopurine.
    CLARKE DA; ELION GB; HITCHINGS GH; STOCK CC
    Cancer Res; 1958 May; 18(4):445-56. PubMed ID: 13536996
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic effects of 6-thioguanine. II. Biosynthesis of nucleic acid purines in vivo and in vitro.
    SARTORELLI AC; LEPAGE GA
    Cancer Res; 1958 Dec; 18(11):1329-35. PubMed ID: 13608442
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and hematologic study of 6[(1-methyl-4-nitro-5-imidazolyl)thio]-purine (B.W.57-322) and related compounds.
    RUNDLES RW; LASZLO J; ITOGA T; HOBSON JB; GARRISON FE
    Cancer Chemother Rep; 1961 Oct; 14():99-115. PubMed ID: 14038848
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
    Saczewski F; Maruszak M; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
    HENDERSON JF; JUNGA IG
    Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthesis of 6-mercaptopurine-dextran derivatives].
    Nuhn P; Schilling E
    Pharmazie; 1975 Sep; 30(9):611-12. PubMed ID: 1187745
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic granulocytic leukemia with the 6-substituted purines 6-mercaptopurine, thioguanine, and 6-chloropurine.
    ELLISON RR; BURCHENAL JH
    Clin Pharmacol Ther; 1960; 1():631-44. PubMed ID: 13726513
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
    Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
    Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary screening of cytotoxic activity of 6-purinyl-N-(2-chlordethyl) thiocarbamate.
    Miko M; Krepelka J; Melka M
    J Chemother; 1989 Jul; 1(4 Suppl):1142-4. PubMed ID: 16312809
    [No Abstract]   [Full Text] [Related]  

  • 10. The metabolism of 6-thioguanine in normal and neoplastic tissues.
    MOORE EC; LePAGE GA
    Cancer Res; 1958 Oct; 18(9):1075-83. PubMed ID: 13596951
    [No Abstract]   [Full Text] [Related]  

  • 11. THE PRIMARY SITE OF INHIBITION BY 6-MERCAPTOPURINE ON THE PURINE BIOSYNTHETIC PATHWAY IN SOME TUMORS IN VIVO.
    BENNETT LL; SIMPSON L; GOLDEN J; BARKER TL
    Cancer Res; 1963 Oct; 23():1574-80. PubMed ID: 14072699
    [No Abstract]   [Full Text] [Related]  

  • 12. The formation of 6-mer captopurine riboside phosphate in ascites tumor cells.
    PATERSON AR
    Can J Biochem Physiol; 1959 Aug; 37(8):1011-23. PubMed ID: 13671389
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine.
    SARTORELLI AC; LEPAGE GA
    Cancer Res; 1958 Sep; 18(8 Part 1):938-42. PubMed ID: 13573368
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic effects of 6-thioguanine. I. Studies on thioguanine-resistant and-sensitive Ehrlich ascites cells.
    SARTORELLI AC; LEPAGE GA; MOORE EC
    Cancer Res; 1958 Nov; 18(10):1232-9. PubMed ID: 13596970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polarographic determination of 6-(4-carboxybutyl)-thiopurine (Cytogran SPOFA)].
    Vachek J
    Cesk Farm; 1965 Jun; 14(5):216-8. PubMed ID: 5838131
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulatory effects of 6-carboxymethylthiopurine on activated murine macrophages.
    De Paula ML; Braga FG; Coimbra ES; Carmo AM; Teixeira HC; Da Silva AD; Souza MA; Ferreira AP
    Chem Biol Drug Des; 2008 Jun; 71(6):563-7. PubMed ID: 18466273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES.
    ELION GB; CALLAHAN S; RUNDLES RW; HITCHINGS GH
    Cancer Res; 1963 Sep; 23():1207-17. PubMed ID: 14070377
    [No Abstract]   [Full Text] [Related]  

  • 18. SUMMARY OF INFORMAL DISCUSSION ON THE ROLE OF PURINE ANTAGONISTS.
    HITCHINGS GH
    Cancer Res; 1963 Sep; 23():1218-25. PubMed ID: 14070378
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease.
    Ansari A; Aslam Z; De Sica A; Smith M; Gilshenan K; Fairbanks L; Marinaki A; Sanderson J; Duley J
    Aliment Pharmacol Ther; 2008 Sep; 28(6):749-57. PubMed ID: 18557988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.